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Abstract: n-3 polyunsaturated fatty acids (PUFAs) have been shown to have preventive effects against
depression. In this study, we aimed to investigate the associations between the intake of n-3 PUFAs
and depression among people according to sex and weight status. We utilized cross-sectional data
from the Shika study in Japan. The study was conducted between 2013 and 2016. Data were collected
from adults older than 65 years. Invitation letters were distributed to 2677 individuals, 2470 of whom
participated in the study (92.3%). We assessed depressive states using the Japanese short version of
the Geriatric Depression Scale (GDS-15). We assessed the intake of n-3 PUFAs using the validated
food frequency questionnaire. One thousand six hundred thirty-three participants provided data,
among which 327 (20.0%) exhibited depressive symptoms. When we performed the stratified analysis
by sex and weight status, there were significant inverse relationships between total n-3 PUFAs,
individual n-3 PUFAs, and n-3/n-6 PUFAs ratio and depressive symptoms in overweight/obese
females. No correlations were observed between n-3 PUFAs intake and depressive states in males.
The results demonstrated a relationship between n-3 PUFAs deficiencies and depressive states,
particularly in overweight/obese females. Dietary modifications may help to prevent depressive
symptoms in overweight/obese females.
Keywords: n-3 PUFA; depressive; sex; weight status; Japanese
1. Introduction
Depression is one of the major illnesses in societies worldwide and affects personal well-being, the ability
to work, and the use of healthcare resources [1]. The diagnosis of major depressive disorder (DSM-V) is
given if an individual has experienced five or more of the identifying symptoms for a period of at least two
weeks. Of these symptoms, at least one must be “a depressed mood” or “markedly diminished interest
or pleasure”. Other identifying symptoms include “significant weight loss”, “insomnia or hypersomnia”,
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“psychomotor agitation or retardation”, “fatigue or loss of energy”, “feelings of worthlessness or excessive
or inappropriate guilt”, “diminished ability to think or concentrate, or indecisiveness”, and “recurrent
thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific
plan for committing suicide” [2]. An estimated 322 million individuals have depression worldwide [3].
A study on people aged 40 years or over in Japan reported 4.3% of males and 6.3% of females had
severe depressive symptoms [4]. Depression is associated with significant disability [5]. Moreover,
the economic cost of depression is a major issue for public health [6].
Depression occurs for various reasons and under different conditions. Nutrition, particularly
polyunsaturated fatty acids (PUFAs), may influence depression. PUFAs are fatty acids that contain two
or more unsaturated carbon–carbon double bonds with hydrogen atoms [7]. PUFAs are categorized
as n-3 and n-6 fatty acids, based on their chemical structures. n-3 PUFAs include eicosapentaenoic
acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA), alpha-linolenic acid (ALA),
and eicosatetraenoic acid (ETA) [7]. Longer-chain n-3 fatty acids (EPA and DHA) are synthesized by
shorter-chain n-3 fatty acids (ALA) [7,8]. However, biological conversion is inefficient in humans [8,9].
In addition, shorter-chain fatty acids cannot be synthesized by humans [10,11]. Therefore, diet is an
important source of these fatty acids [12].
n-3 PUFAs have been hypothesized to have preventive effects against depression. Previous studies
have investigated the relationship between n-3 PUFAs dietary intake and depression. However,
the findings obtained were conflicting [13]. Observational studies conducted on general populations
are important from a prevention perspective.
Previous epidemiological studies have shown that the prevalence rate of depression is about
twice in females compared to males [14]. In addition, a large number of epidemiological studies
and meta-analyses have confirmed obesity to be associated with depression [15]. In recent decades,
the consumption of n-3 PUFAs has been reduced and replaced by saturated fats from domestic animals
and n-6 PUFAs from common vegetable oils and other sources, which changed dietary intakes of n-3
and n-6 PUFAs dramatically [16]. The higher prevalence rate of depression in females or obese people
could be attributed to a vulnerability to n-3 PUFAs deficiency in these people. However, only a few
researchers have evaluated the influences of sex or weight status on the relationship between n-3 PUFAs
intake and depression. Understanding the influences of sex and weight status on the relationship
between n-3 PUFAs intake and depression will be informative to address the target population and to
maximize the beneficial effect so as to prevent depression.
Therefore, in this study, we aimed to investigate the associations between the intake of n-3 PUFAs
and depression among people according to sex and weight status.
2. Materials and Methods
2.1. Study Population
We utilized cross-sectional data from the Shika study. The Shika study is an ongoing population-based
survey that aims to develop advanced preventive methods for lifestyle-related diseases. It includes
interviews, self-administered questionnaires, and comprehensive health examinations. Shika town is
located in a rural area of the Ishikawa prefecture, Japan. The town has more than 20,000 residents [17].
Major industries include electronic component manufacturing, retail, and medical and welfare
services [18]. The climate is humid subtropical. We selected four model districts in Shika town for the
present study, which was conducted between October 2013 and December 2016. Data were collected
from adults older than 65 years in the model districts. All adults older than 65 years who lived in
these districts were eligible to participate in the present study. Invitation letters to participate were
distributed to 2677 individuals, 2470 of whom participated in the study (92.3%). All subjects gave
their written informed consent for inclusion before they participated in the study. The study was
conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics
Committee of Kanazawa University (No.1491).
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2.2. Depressive States
We assessed depressive states using the Japanese short version of the Geriatric Depression Scale
(GDS-15), which consists of 15 questions developed for self-administrative surveys [19]. Higher scores
indicate greater depressive symptoms [19]. A study that evaluated the validity of the Japanese version of
GDS-15 recommended a cut-off score of 6/7 [20]. We used a cut-off point of 7, with scores ≥7 indicating
depressive symptoms. We included participants who answered more than 12 out of the 15 questions in
the analysis.
2.3. Nutrient Assessment
We assessed the intake of n-3 PUFAs: total n-3 PUFAs, EPA+DHA, individual PUFAs (EPA, DHA,
ALA, DPA, and ETA), n-3/n-6 PUFAs ratio, and n-6 PUFAs from the validated food frequency
questionnaire. We used the brief-type self-administered dietary questionnaire (BDHQ) [21–23]. BDHQ
is based on a comprehensive version of a validated self-administered questionnaire (i.e., DHQ) [24].
BDHQ asks about dietary history in the preceding month. BDHQ lists 58 food items [22,23]. The intake
of n-3 PUFAs was estimated using a computer algorithm for BDHQ [25,26]. Participants who reported
an energy intake per day of less than 600 kcal/day (half of the required energy for the lowest physical
activity category) or more than 4000 kcal/day (1.5 times the energy intake required for the highest
physical activity category) were excluded from the analyses because they were either extremely low or
extremely high energy intakes [27]. The n-3 PUFAs intake was expressed as a percentage of the total
energy intake.
2.4. Other Variables
The weight status was based on body mass index (BMI), calculated using self-reported heights
and weights. BMI was computed based on the standard formula (kg/m2) [28]. It was used to
classify participants as underweight (<18.50), normal-weight (18.50–24.99), overweight (≥25.00),
or obese (≥30.00), based on the World Health Organization reference [28]. We categorized them
as underweight/normal-weight (<25.00) or overweight/obese (≥25.00). Covariates included in the
multivariable analysis consisted of age, energy intake (kcal/day), carbohydrate intake (% energy),
education (years of going to school), social activity (doing work or volunteering), living status
(living alone or with someone), smoking status (current smoker, ex-smoker, or non-smoker),
alcohol drinking, and history of chronic diseases (hypertension, stroke, myocardial infarction, diabetes,
and hyperlipidemia). In the present study, participants who reported a history of stroke and/or
myocardial infarction also had hypertension and/or diabetes. Therefore, we focused on hypertension,
diabetes, and hyperlipidemia as confounders.
2.5. Statistical Analysis
Descriptive statistics were used to describe participant characteristics, depressive states, and n-3
PUFAs intake. Continuous variables were summarized as means and standard deviation (SD).
Categorical variables were presented as numbers (N) and percentages (%). Differences in characteristics,
depressive states, and n-3 PUFAs intake between sexes were assessed using the Student’s t-test
(continuous variables) and the χ2 test (categorical variables). Differences in characteristics and n-3
PUFAs intake between participants with and without depressive symptoms were assessed using the
Student’s t-test and the χ2 test. Differences in the intakes of n-3 PUFAs among participants were
also assessed using a two-way analysis of variance (two-way ANOVA) with depressive states and
sex as the main factors. Both depressive states and sex were between factors. Tests for interactions
of depressive states and sex were done to assess sex differences. We conducted post hoc tests in
order to examine the differences in the n-3 PUFAs intakes between participants with and without
depressive symptoms in each sex. The two-way ANOVA was also used with depressive states and
weight status as the main factors. We also tested for interactions of depressive states and weight status.
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Post hoc tests in each weight status category were conducted. Participants were stratified by sex and
weight status for multivariate logistic regression analyses. The dependent variable was the existence
of depressive symptoms. The independent variables were the intakes of each n-3 PUFAs, the n-3/n-6
PUFAs ratio, and n-6 PUFAs. Multivariate logistic regression analyses were adjusted by age, energy
intake, carbohydrate intake, education, social activity, living status, smoking status, alcohol drinking,
and history of chronic diseases. The odds ratios (ORs) and 95% confidence intervals (CIs) of each
n-3 PUFAs for depressive states were calculated. A type I error of 0.05 was used for all analyses,
with P values between 0.05 and 0.10 considered as borderline significance. The Statistical Package for
Social Science (SPSS) for MS Windows, version 23.0 (SPSS, Inc., New York, NY, USA) was used for
statistical analyses.
3. Results
3.1. Participant Characteristics
The characteristics of the studied population are shown in Table 1. A total of 1633 participants
provided data for the variables of interest and were included in the analyses. The number of males
was 720, while that of females was 913. The average ages of the participants were 73.5 (SD = 6.8)
years for males and 75.2 (SD = 7.8) years for females. A total of 327 (20.0%) of participants had
depressive symptoms. Among them, 147 (20.4%) were male and 180 (19.7%) were female. Females had
significantly higher total n-3 PUFAs, ALA, and n-6 PUFAs intakes than males. The dietary sources of
n-3 PUFAs in the studied population are shown in Table S1.
Table 1. Participant characteristics.
Total (N = 1633) Male (N = 720) Female (N = 913)
p *
Ave (n) SD (%) Ave (n) SD (%) Ave (n) SD (%)
Age 74.5 7.4 73.5 6.8 75.2 7.8 <0.001
BMI 22.9 3.2 23.3 3 22.6 3.3 <0.001
Energy (kcal) 1824.1 610.9 2014.5 632.3 1673.9 549.1 <0.001
Carbohydrate (% energy) 55.4 8.5 54.0 8.9 56.5 8.1 <0.001
Education 10.4 2.4 10.7 2.5 10.1 2.2 <0.001
Social activity (none) 1237 78.3% 523 75.0% 714 80.9% 0.005
Household size (being single) 207 12.9% 56 7.9% 151 16.9% <0.001
Drinking 905 58.5% 526 75.4% 379 44.6% <0.001
Smoking 165 10.4% 146 20.7% 19 2.1% <0.001
Hypertension 643 39.4% 310 43.1% 333 36.5% 0.007
Diabetes 229 14.0% 122 16.9% 107 11.7% 0.003
Hyperlipidemia 314 19.2% 102 14.2% 212 23.2% <0.001
Depressive state 327 20.0% 147 20.4% 180 19.7% 0.725
Total n-3 PUFAs (% energy) 1.382 0.481 1.338 0.470 1.417 0.487 0.001
EPA+DHA (% energy) 0.539 0.315 0.531 0.310 0.545 0.320 0.368
EPA (% energy) 0.204 0.127 0.201 0.124 0.207 0.129 0.390
DHA (% energy) 0.335 0.189 0.330 0.186 0.339 0.192 0.354
DPA (% energy) 0.058 0.033 0.057 0.033 0.059 0.034 0.417
ALA (% energy) 0.714 0.224 0.679 0.211 0.741 0.230 <0.001
ETA (% energy) 0.020 0.013 0.020 0.012 0.020 0.013 0.551
n-3/n-6 PUFAs ratio 0.305 0.107 0.307 0.105 0.302 0.108 0.343
n-6 PUFAs 5.149 1.339 4.928 1.265 5.323 1.370 <0.001
* t-tests for continuous variables and chi-square tests for categorical variables by sex (p-values under 0.05 are
highlighted in bold).
3.2. Participant Characteristics and n-3 PUFAs Intake According to Depressive States
Participant characteristics and n-3 PUFAs intake according to depressive states are shown in Table 2.
Participants with depressive symptoms were significantly older than those without. Participants
with depressive symptoms had a significantly lower energy intake, less education, less social activity,
less household size, less alcohol drinking than those without. The levels of seven n-3 PUFAs were
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significantly lower in participants with depressive symptoms than in those without. Although no
significant difference was observed between the two groups, the n-3/n-6 PUFAs ratio and the n-6
PUFAs were slightly lower in participants with depressive symptoms.
Table 2. Participant characteristics and n-3 polyunsaturated fatty acids (PUFAs) intake according to
depressive states (t-tests and chi-square tests).
Without Depressive States (N = 1306) With Depressive States (N = 327)
p *
Ave (n) SD (%) Ave (n) SD (%)
Age 73.8 7.1 77.3 8.1 <0.001
BMI 23 3.1 22.6 3.5 0.064
Energy (kcal) 1852.2 618.2 1712 568 <0.001
Carbohydrate (% energy) 55.1 8.5 56.6 8.5 0.004
Education 10.5 2.4 9.9 2.4 <0.001
Social activity (none) 962 76.0% 275 87.6% <0.001
Household size (being single) 159 12.4% 48 15.0% 0.206
Drinking 746 60.3% 159 51.1% 0.003
Smoking 138 10.8% 27 8.7% 0.264
Hypertension 511 39.1% 132 40.4% 0.682
Diabetes 180 13.8% 49 15.0% 0.576
Hyperlipidemia 258 19.8% 56 17.1% 0.278
Total n-3 PUFAs (% energy) 1.402 0.487 1.303 0.450 <0.001
EPA+DHA (% energy) 0.548 0.321 0.504 0.290 0.017
EPA (% energy) 0.208 0.129 0.189 0.117 0.011
DHA (% energy) 0.340 0.192 0.315 0.174 0.033
DPA (% energy) 0.059 0.034 0.055 0.030 0.032
ALA (% energy) 0.722 0.224 0.679 0.220 0.002
ETA (% energy) 0.021 0.013 0.019 0.011 0.028
n-3/n-6 PUFAs ratio 0.307 0.109 0.295 0.100 0.082
n-6 PUFAs 5.179 1.332 5.026 1.363 0.063
* t-tests for continuous variables and chi-square tests for categorical variables by depressive states (p-values under
0.05 are highlighted in bold).
3.3. Influence of Sex on the Association between n-3 PUFAs Intake and Depressive States
The influence of sex on the association between n-3 PUFAs intake and depressive states is shown
in Table 3. There was a significant or borderline significant main effect of depressive states in seven n-3
PUFAs, excluding n-3/n-6 PUFAs ratio and n-6 PUFAs. The tests for interactions of sex and depressive
states were statistically significant or tended to be significant in seven n-3 PUFAs and n-6 PUFAs,
excluding n-3/n-6 PUFAs ratio, which indicated that the associations between n-3 PUFAs intake and
depressive states differed by sex. Post hoc tests showed, among females, the levels of all seven n-3
PUFAs, n-3/n-6 PUFAs ratio, and n-6 PUFAs were significantly lower in participants with depressive
states than in those without. In contrast, in males, none of the n-3 PUFAs, n-3/n-6 PUFAs ratio, or n-6
PUFAs levels were significantly lower in participants with depressive symptoms than in those without.
Table 3. Influence of sex on the association between n-3 PUFAs intake and depressive states
(two-way ANOVA).
Without Depressive States
(N = 1306)
With Depressive States
(N = 327)
p1 a p2 b p3 c p4 d
Average
95% CI
Average
95% CI
Lower Upper Lower Upper
Total n-3 PUFAs Male (N = 720) 1.340 1.301 1.379 1.329 1.254 1.403
0.002 0.008 0.798 <0.001Female (N = 914) 1.450 1.415 1.486 1.281 1.217 1.346
EPA+DHA Male (N = 720) 0.531 0.505 0.556 0.533 0.484 0.582
0.045 0.034 0.937 0.002Female (N = 914) 0.561 0.537 0.585 0.480 0.440 0.521
EPA Male (N = 720) 0.201 0.191 0.211 0.201 0.181 0.221
0.030 0.030 0.995 <0.001Female (N = 914) 0.213 0.204 0.223 0.179 0.163 0.196
DHA Male (N = 720) 0.329 0.314 0.345 0.332 0.302 0.361
0.058 0.037 0.898 0.003Female (N = 914) 0.348 0.334 0.362 0.301 0.277 0.325
DPA Male (N = 720) 0.057 0.055 0.060 0.058 0.052 0.063
0.055 0.043 0.944 0.003Female (N = 914) 0.060 0.058 0.063 0.052 0.048 0.056
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Table 3. Cont.
Without Depressive States
(N = 1306)
With Depressive States
(N = 327)
p1 a p2 b p3 c p4 d
Average
95% CI
Average
95% CI
Lower Upper Lower Upper
ALA Male (N = 720) 0.681 0.664 0.699 0.668 0.633 0.704
0.004 0.047 0.528 <0.001Female (N = 914) 0.754 0.738 0.771 0.687 0.654 0.720
ETA Male (N = 720) 0.020 0.019 0.021 0.020 0.018 0.022
0.047 0.053 0.976 0.003Female (N = 914) 0.021 0.020 0.022 0.018 0.016 0.020
n-3/n-6 PUFAs Male (N = 720) 0.308 0.299 0.316 0.307 0.290 0.324
0.114 0.139 0.946 0.022ratio Female (N = 914) 0.306 0.298 0.314 0.286 0.272 0.300
n-6 PUFAs Male (N = 720) 4.927 4.819 5.036 4.933 4.719 5.147
0.102 0.089 0.964 0.013Female (N = 914) 5.377 5.281 5.473 5.102 4.908 5.295
a: Between with and without depressive states groups. b: Interaction by depressive states groups and sex.
c: Bonferroni post hoc tests between males with and without depressive symptoms. d: Bonferroni post hoc tests
between females with and without depressive symptoms. a–d: p-values under 0.05 are highlighted in bold.
3.4. Influence of Weight Status on the Association between n-3 PUFAs Intake and Depressive States
The influence of weight status on the association between n-3 PUFAs intake and depressive states
is shown in Table 4. The main effects of depressive states were significant or tended to be significant
in all n-3 PUFAs, the n-3/n-6 PUFAs ratio, and n-6 PUFAs. The interactions of weight status and
depressive states tended to be statistically significant in EPA+DHA, EPA, DHA, and DPA. When we
performed post hoc analyses among overweight/obese participants, the levels of seven n-3 PUFAs and
the n-3/n-6 PUFAs ratio were significantly lower or tended to be significantly lower in participants
with depressive symptoms than without depressive symptoms.
Table 4. Influence of weight status on the association between n-3 PUFAs intake and depressive states
(two-way ANOVA).
Without Depressive States
(N = 1306)
With Depressive States
(N = 327)
p1 a p2 b p3 cd p4 d
Average
95% CI
Average
95% CI
Lower Upper Lower Upper
Total n-3 PUFAs Underweight/normal-weight(N = 1255) 1.392 1.362 1.422 1.318 1.260 1.377 <0.001 0.109 0.028 0.003
Overweight/obese
(N = 378) 1.434 1.380 1.487 1.244 1.131 1.357
EPA+DHA Underweight/normal-weight(N = 1255) 0.544 0.525 0.564 0.518 0.480 0.557 0.005 0.083 0.235 0.010
Overweight/obese
(N = 378) 0.559 0.524 0.594 0.451 0.376 0.525
EPA Underweight/normal-weight(N = 1255) 0.207 0.199 0.215 0.195 0.179 0.210 0.003 0.091 0.176 0.009
Overweight/obese
(N = 378) 0.212 0.198 0.227 0.168 0.138 0.198
DHA Underweight/normal-weight( N = 1255) 0.338 0.326 0.349 0.323 0.300 0.346 0.006 0.079 0.283 0.011
Overweight/obese
(N = 378) 0.347 0.326 0.368 0.282 0.238 0.327
DPA Underweight/normal-weight(N = 1255) 0.059 0.057 0.061 0.056 0.052 0.060 0.007 0.094 0.260 0.013
Overweight/obese
(N = 378) 0.060 0.056 0.064 0.049 0.041 0.057
ALA Underweight/normal-weight(N = 1255) 0.717 0.703 0.731 0.677 0.649 0.704 0.005 0.669 0.010 0.067
Overweight/obese
(N = 378) 0.740 0.715 0.765 0.686 0.633 0.738
ETA Underweight/normal-weight(N = 1255) 0.020 0.020 0.021 0.019 0.018 0.021 0.007 0.119 0.221 0.016
Overweight/obese
(N = 378) 0.021 0.020 0.022 0.017 0.014 0.020
n-3/n-6 PUFAs
ratio
Underweight/normal-weight
(N = 1255) 0.307 0.300 0.313 0.300 0.287 0.313 0.030 0.201 0.007 0.014
Overweight/obese
(N = 378) 0.307 0.295 0.319 0.280 0.254 0.305
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Table 4. Cont.
Without Depressive States
(N = 1306)
With Depressive States
(N = 327)
p1 a p2 b p3 cd p4 d
Average
95% CI
Average
95% CI
Lower Upper Lower Upper
n-6 PUFAs Underweight/normal-weight(N = 1255) 5.148 5.065 5.232 5.018 4.854 5.181 0.079 0.647 0.162 0.211
Overweight
(N = 378) 5.279 5.130 5.429 5.056 4.740 5.372
a: Between with and without depressive states groups. b: Interaction by depressive states and weight status.
c: Bonferroni post hoc tests between underweight/normal-weight participants with and without depressive symptoms.
d: Bonferroni post hoc tests between overweight/obese people with and without depressive symptoms. a–d: p-values
under 0.05 are highlighted in bold.
3.5. Relationships between n-3 PUFAs Intake and Depressive States by Sex and Weight Status
The relationships between n-3 PUFAs intake and depressive states by sex and weight status are
shown in Table 5 and Figure 1. When we conducted stratified analyses by sex and weight status,
there were significant inverse relationships for total n-3 PUFAs, EPA+DHA, EPA, DHA, DPA, ETA,
and n-3/n-6 PUFAs ratio in overweight/obese females. The intakes of total n-3 PUFAs and ALA were also
inversely related to depressive symptoms among underweight/normal-weight females. No correlations
were observed between n-3 PUFAs intake or n-3/n-6 PUFAs ratio and depressive states in males.
Table 5. Relationship between n-3 PUFAs intake and depressive states by sex and weight status (logistic
regression analysis).
Weight Status PUFAs
Male Female
OR
95% CI
p OR
95% CI
p *
Lower Upper Lower Upper
Underweight/normal-weight Total n-3 PUFAs 1.000 1.000 1.001 0.570 0.999 0.998 1.000 0.020
EPA+DHA 1.000 1.000 1.001 0.362 1.000 0.999 1.000 0.407
EPA 1.001 0.999 1.003 0.383 0.999 0.997 1.001 0.330
DHA 1.001 0.999 1.002 0.349 0.999 0.998 1.001 0.467
DPA 1.005 0.996 1.013 0.317 0.998 0.990 1.005 0.544
ALA 1.000 0.998 1.001 0.639 0.998 0.997 1.000 0.013
ETA 1.011 0.988 1.034 0.364 0.994 0.975 1.014 0.550
n-3/n-6 PUFAs ratio 1.691 0.143 20.050 0.677 0.544 0.080 3.719 0.535
n-6 PUFAs 0.999 0.806 1.239 0.994 0.856 0.693 1.057 0.148
Overweight/obesity Total n-3 PUFAs 1.000 0.999 1.002 0.604 0.997 0.996 0.999 0.007
EPA+DHA 1.000 0.999 1.002 0.557 0.997 0.994 0.999 0.007
EPA 1.001 0.997 1.005 0.547 0.991 0.985 0.997 0.005
DHA 1.001 0.998 1.003 0.565 0.995 0.990 0.999 0.009
DPA 1.004 0.989 1.020 0.579 0.968 0.944 0.992 0.009
ALA 1.000 0.998 1.002 0.955 1.000 0.997 1.003 0.783
ETA 1.009 0.970 1.050 0.640 0.922 0.866 0.982 0.012
n-3/n-6 PUFAs ratio 2.856 0.063 130.369 0.590 0.001 0.001 0.011 0.003
n-6 PUFAs 0.993 0.695 1.417 0.968 1.441 0.830 2.502 0.195
* Adjusted for age, energy, carbohydrate, education, social activity, household size, drinking, smoking, hypertension,
diabetes, and hyperlipidemia (p-values under 0.05 are highlighted in bold).
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Figure 1. (a) Relationships between n-3 PUFAs intake and depressive states in males by weight status
(* p-values under 0.05, ** p-values under 0.01), and (b) relationships between n-3 PUFAs intake and
depressive states in females by weight status (* p-values under 0.05, ** p-values under 0.01).
4. Discussion
The results of the present study showed that a higher intake of n-3 PUFAs was associated with
a lower risk of depressive symptoms, especially in overweight/obese females. To the best of our
knowledge, this is the first study to demonstrate differences according to sex and weight status on the
relationship between n-3 PUFAs intake and depressive symptoms.
The present results are consistent with previous findings, showing that n-3 PUFAs intake is
inversely associated with depression [29]. According to a systematic review, most studies found
that n-3 PUFAs intake was inversely associated with depression, though some studies found no
association [29]. The difference observed between these findings may be due to the target population
examined (middle-aged vs. elderly individuals) or the study design. In addition, most of the studies
that investigated the relationship between n-3 PUFAs intake and depression were not stratified by
sex or weight status. This may limit appropriate comparisons with the present results, which were
stratified by sex and weight status.
Regarding participant characteristics, a relationship was found in females but not in males.
This could be due to the difference in sample size between the males and females in our study
(n = 720 (males) and n = 913 (females)). Meanwhile, several epidemiological studies have found
inverse associations between n-3 PUFAs and depressive symptoms in females but not in males [30–33].
Colangelo et al. [30] reported that higher total n-3 PUFAs, EPA+DHA, EPA, and DHA intakes predicted
less severe depressive symptoms in females only. Beydoun et al. [31] also found that n-3 PUFAs
intake and the n-3/n-6 PUFAs ratio were inversely associated with depressive symptoms in females.
Persons et al. [33] found a positive association of dietary DHA+EPA with baseline depressive symptoms,
though they found no associations at follow-up. In the study of Lucas et al. [33], although an inverse
association of α-linolenic acid with clinical depression was found, there was no association for total
n-3 PUFAs. They also found that depression was positively linked to the n-3/n-6 PUFAs ratio.
Sex differences in the association between the intake of n-3 PUFAs and depressive symptoms
can be explained by some mechanisms. Depression is considered to be secondary to inflammatory
disorders. For example, inflammatory proteins, such as C-reactive protein (CRP) [34], and cytokines,
such as interleukin (IL)-6 [35] and tumor necrosis factor (TNF)-α [36], have been elevated in people
with depression. Pro-inflammatory cytokines alter serotonin metabolism, reduce synaptic plasticity,
and increase the risk of developing depression [37–39]. The anti-inflammatory effects of n-3 PUFAs
have been considered to play an important role in counteracting the inflammatory processes occurring
in depression [40]. One possible explanation is that plasma DHA levels are higher in females than in
males independent of DHA intake due to sex hormones [41,42]. It has been shown that estrogens may
contribute to higher DHA concentrations [41,42].
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It has not been clarified whether n-3 PUFAs intake is associated with depressive states among
overweight/obese people. We could not find other epidemiological studies which focused on the
modification by weight status on the association between n-3 PUFAs intake and depressive symptoms.
It is suggested that obesity is also a disorder of inflammation [43]. Therefore, inflammation could
link obesity with depression [44]. Hence, n-3 PUFAs could play a role in depressive symptoms via
inflammatory processes, especially in the context of being overweight or obese.
Regarding ALA, a correlation was not observed in overweight/obese people. This could be due to
a high n-6 PUFAs intake in overweight/obese people. Some studies suggest that overweight/obese
people consume a diet with a low n-3/n-6 ratio [45]. It is reported that very little ALA is converted to
EPA and DHA in the presence of high levels of n-6 PUFAs [46,47].
Furthermore, estrogen has been shown to increase inflammation [48,49]. Females have a stronger
immune response than males [49,50]. The observed results in overweight/obese females could be due
to a stronger immune response in females and the anti-inflammatory effects of n-3 PUFAs compared to
males in all weight categories and underweight/normal-weight females.
A cross-national ecological study reported that an intake of 0.750 g/day of n-3 PUFAs was sufficient
to protect 98% of the population from the risk of depression [51]. The World Health Organization
(WHO) recommended an intake of 0.250 g/day of EPA plus DHA for non-pregnant/non-lactating adult
females [52]. Dietary sources of longer-chain n-3 PUFAs are fish and wild animals (e.g., fatty fish,
white fish, shellfish, other sea foods, eggs, and wild game) [11,53–55]. Dietary sources of shorter-chain
n-3 PUFAs are plants (e.g., nuts, seeds, flaxseed, and rapeseed oil) [11,53–55].
Our study had several limitations. The study design was cross-sectional; therefore, the causality
of relationships cannot be assessed. In addition, we obtained data from a subsample of a larger
cohort. This may have introduced a selection bias, because these subsamples may not resemble
the target population. Furthermore, despite being validated, the depression scale only suggests the
presence of a depressive symptom. Another limitation is that self-reported assessment methods were
subject to recall bias or misreporting. Overweight or obese individuals are more likely to misreport
information [56]. However, the instruments used in the present study were validated, and evidence
suggests that errors by misreporting may be cancelled out, at least in part, by energy adjustments [57,58].
5. Conclusions
The results of the present study demonstrated a relationship between n-3 PUFAs deficiencies
and depressive states, particularly in overweight/obese females. Our findings suggest that dietary
modifications may help to prevent depressive symptoms in overweight/obese females, informing how
interventions can effectively target specific populations for prevention. Further research is needed to
clarify whether this relationship is consistent.
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